139 related articles for article (PubMed ID: 9354191)
1. Controlled trial of oral 5-aminosalicylic acid for the prevention of early relapse in Crohn's disease.
de Franchis R; Omodei P; Ranzi T; Brignola C; Rocca R; Prada A; Pera A; Vecchi M; Del Piano M; Ferrara A; Belloli C; Piodi L; Framarin L; Astegiano M; Riccioli FA; Meucci G
Aliment Pharmacol Ther; 1997 Oct; 11(5):845-52. PubMed ID: 9354191
[TBL] [Abstract][Full Text] [Related]
2. Mesalazine (Mesasal/Claversal) 1.5 g b.d. vs. placebo in the maintenance of remission of patients with Crohn's disease.
Thomson AB; Wright JP; Vatn M; Bailey RJ; Rachmilewitz D; Adler M; Wilson-Lynch KA
Aliment Pharmacol Ther; 1995 Dec; 9(6):673-83. PubMed ID: 8824656
[TBL] [Abstract][Full Text] [Related]
3. Coated oral 5-aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease. International Mesalazine Study Group.
Aliment Pharmacol Ther; 1990 Feb; 4(1):55-64. PubMed ID: 2104074
[TBL] [Abstract][Full Text] [Related]
4. Oral 4-aminosalicylic acid versus 5-aminosalicylic acid slow release tablets. Double blind, controlled pilot study in the maintenance treatment of Crohn's ileocolitis.
Schreiber S; Howaldt S; Raedler A
Gut; 1994 Aug; 35(8):1081-5. PubMed ID: 7926910
[TBL] [Abstract][Full Text] [Related]
5. Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
Florent C; Cortot A; Quandale P; Sahmound T; Modigliani R; Sarfaty E; Valleur P; Dupas JL; Daurat M; Faucheron JL; Lerebours E; Michot F; Belaiche J; Jacquet N; Soulé JC; Rothman N; Gendre JP; Malafosse M
Eur J Gastroenterol Hepatol; 1996 Mar; 8(3):229-33. PubMed ID: 8724022
[TBL] [Abstract][Full Text] [Related]
6. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's Disease.
Akobeng AK; Gardener E
Cochrane Database Syst Rev; 2005 Jan; (1):CD003715. PubMed ID: 15674913
[TBL] [Abstract][Full Text] [Related]
7. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group.
Sutherland LR; Martin F; Bailey RJ; Fedorak RN; Poleski M; Dallaire C; Rossman R; Saibil F; Lariviere L
Gastroenterology; 1997 Apr; 112(4):1069-77. PubMed ID: 9097988
[TBL] [Abstract][Full Text] [Related]
8. Aminosalicylates for induction of remission or response in Crohn's disease.
Lim WC; Hanauer S
Cochrane Database Syst Rev; 2010 Dec; (12):CD008870. PubMed ID: 21154400
[TBL] [Abstract][Full Text] [Related]
9. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.
Gordon M; Naidoo K; Thomas AG; Akobeng AK
Cochrane Database Syst Rev; 2011 Jan; (1):CD008414. PubMed ID: 21249709
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.
Lochs H; Mayer M; Fleig WE; Mortensen PB; Bauer P; Genser D; Petritsch W; Raithel M; Hoffmann R; Gross V; Plauth M; Staun M; Nesje LB
Gastroenterology; 2000 Feb; 118(2):264-73. PubMed ID: 10648454
[TBL] [Abstract][Full Text] [Related]
11. Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
Modigliani R; Colombel JF; Dupas JL; Dapoigny M; Costil V; Veyrac M; Duclos B; Soulé JC; Gendre JP; Galmiche JP; Danne O; Cadiot G; Lamouliatte H; Belaïche J; Mary JY
Gastroenterology; 1996 Mar; 110(3):688-93. PubMed ID: 8608877
[TBL] [Abstract][Full Text] [Related]
12. A controlled double blind multicenter study of the effectiveness of 5-aminosalicylic acid in patients with Crohn's disease in remission.
Arber N; Odes HS; Fireman Z; Lavie A; Broide E; Bujanover Y; Becker S; Pomerantz I; Moshkowitz M; Patz J
J Clin Gastroenterol; 1995 Apr; 20(3):203-6. PubMed ID: 7797827
[TBL] [Abstract][Full Text] [Related]
13. 5-aminosalicylates prevent relapse of Crohn's disease after surgically induced remission: systematic review and meta-analysis.
Ford AC; Khan KJ; Talley NJ; Moayyedi P
Am J Gastroenterol; 2011 Mar; 106(3):413-20. PubMed ID: 20717106
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis.
Ford AC; Kane SV; Khan KJ; Achkar JP; Talley NJ; Marshall JK; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):617-29. PubMed ID: 21407190
[TBL] [Abstract][Full Text] [Related]
15. Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease.
Brignola C; Iannone P; Pasquali S; Campieri M; Gionchetti P; Belluzzi A; Basso O; Miglioli M; Barbara L
Dig Dis Sci; 1992 Jan; 37(1):29-32. PubMed ID: 1728527
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate for induction of remission in refractory Crohn's disease.
McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
[TBL] [Abstract][Full Text] [Related]
17. Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study.
Mahmud N; Kamm MA; Dupas JL; Jewell DP; O'Morain CA; Weir DG; Kelleher D
Gut; 2001 Oct; 49(4):552-6. PubMed ID: 11559654
[TBL] [Abstract][Full Text] [Related]
18. Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease.
Prantera C; Pallone F; Brunetti G; Cottone M; Miglioli M;
Gastroenterology; 1992 Aug; 103(2):363-8. PubMed ID: 1634054
[TBL] [Abstract][Full Text] [Related]
19. Early post-operative endoscopic recurrence in Crohn's disease patients: data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort.
Orlando A; Mocciaro F; Renna S; Scimeca D; Rispo A; Lia Scribano M; Testa A; Aratari A; Bossa F; Tambasco R; Angelucci E; Onali S; Cappello M; Fries W; D'Incà R; Martinato M; Castiglione F; Papi C; Annese V; Gionchetti P; Rizzello F; Vernia P; Biancone L; Kohn A; Cottone M
J Crohns Colitis; 2014 Oct; 8(10):1217-21. PubMed ID: 24630485
[TBL] [Abstract][Full Text] [Related]
20. 5-aminosalicylic acid dependency in Crohn's disease: a Danish Crohn Colitis Database study.
Duricova D; Pedersen N; Elkjaer M; Jensen JK; Munkholm P
J Crohns Colitis; 2010 Nov; 4(5):575-81. PubMed ID: 21122562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
